Uygun, V. Et Al. 2009. Piperacillin/Tazobactam Versus Cefepime for the Empirical Treatment of Pediatric Cancer Patients With Neutropenia and Fever: A Randomized and Open-Label Study. PEDIATRIC BLOOD & CANCER , vol.53, no.4 , 610-614.

Uygun, V., Karasu, G. T., ÖĞÜNÇ, M. D., Yesilipek, A., & Hazar, V., (2009). Piperacillin/Tazobactam Versus Cefepime for the Empirical Treatment of Pediatric Cancer Patients With Neutropenia and Fever: A Randomized and Open-Label Study. PEDIATRIC BLOOD & CANCER , vol.53, no.4, 610-614.

Uygun, Vedat Et Al. "Piperacillin/Tazobactam Versus Cefepime for the Empirical Treatment of Pediatric Cancer Patients With Neutropenia and Fever: A Randomized and Open-Label Study," PEDIATRIC BLOOD & CANCER , vol.53, no.4, 610-614, 2009

Uygun, Vedat Et Al. "Piperacillin/Tazobactam Versus Cefepime for the Empirical Treatment of Pediatric Cancer Patients With Neutropenia and Fever: A Randomized and Open-Label Study." PEDIATRIC BLOOD & CANCER , vol.53, no.4, pp.610-614, 2009

Uygun, V. Et Al. (2009) . "Piperacillin/Tazobactam Versus Cefepime for the Empirical Treatment of Pediatric Cancer Patients With Neutropenia and Fever: A Randomized and Open-Label Study." PEDIATRIC BLOOD & CANCER , vol.53, no.4, pp.610-614.

@article{article, author={Vedat Uygun Et Al. }, title={Piperacillin/Tazobactam Versus Cefepime for the Empirical Treatment of Pediatric Cancer Patients With Neutropenia and Fever: A Randomized and Open-Label Study}, journal={PEDIATRIC BLOOD & CANCER}, year=2009, pages={610-614} }